With prescription drug prices soaring and President Donald Trump vowing to take action, an old idea is gaining fresh traction: allowing Americans to buy medicines from foreign pharmacies at far lower prices.
Inside the Industry
Providence Health Plan has threatened to pull out of the state health insurance market if they are forced to cover abortion services, citing First Amendment rights in an effort to block a bill that requires coverage of abortion and other reproductive health services with no additional cost-sharin
Correction: Due to a spreadsheet error, The Lund Report incorrectly reported rises in profits at a number of hospitals that, in fact, saw profits fall from the third quarter of 2015 to the third quarter of 2016.
The Oregon Health Authority wants Oregon hospitals to step up their data reporting to include information on emergency department visits, but the Oregon Association of Hospitals and Health Systems is fighting the legislation.
The Congressional Budget Office estimates that 24 million people would lose their health insurance coverage under “Trumpcare” by 2026, more than half of them poor people receiving Medicaid.
Sen. Elizabeth Steiner Hayward, D-Portland, has introduced two of her own pharmaceutical price reform bills into the Senate, keeping pressure on the Legislature to do something about the skyrocketing costs of prescription drugs in case similar legislation falters in the House.
As a pediatrician at The Children’s Clinic in 2008, Dr. R.J. Gillespie saw a happy six-month-old baby with a clearly depressed mother. By the time that baby was nine months old, he failed his developmental screening. At age two, the child was standing in a corner screaming.
The number of people receiving health insurance through small insurers or buying individual marketplace plans in Oregon dropped significantly in 2016, with 74,422 fewer people covered under the state’s major plans at the end of last year than a year earlier.
Patient advocates and pharmaceutical companies are backing legislation that would give physicians an easier time prescribing medication and bypassing “step-therapy” protocols, which health insurers use to limit the dispensation and purchase of high-cost drugs.
Psychologists find themselves at odds with insurance companies over reimbursement, and, for the first time, the Oregon Psychological Association is taking a pro-active stance.
“It’s getting more and more difficult to get reimbursed when people have serious mental health issues,” Shana Koslofsky, PhD, president of the Oregon Psychological Association, told The Lund Report.